- Home
- IMNM vs WLKP Comparison
IMNM vs WLKP Comparison
Compare IMNM & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- WLKP
- Stock Information
- Founded
- IMNM 2006
- WLKP 2014
- Country
- IMNM United States
- WLKP United States
- Employees
- IMNM N/A
- WLKP N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- WLKP Major Chemicals
- Sector
- IMNM Health Care
- WLKP Industrials
- Exchange
- IMNM Nasdaq
- WLKP Nasdaq
- Market Cap
- IMNM 806.1M
- WLKP 819.3M
- IPO Year
- IMNM 2020
- WLKP 2014
- Fundamental
- Price
- IMNM $6.73
- WLKP $23.10
- Analyst Decision
- IMNM Strong Buy
- WLKP
- Analyst Count
- IMNM 5
- WLKP 0
- Target Price
- IMNM $26.60
- WLKP N/A
- AVG Volume (30 Days)
- IMNM 1.0M
- WLKP 24.0K
- Earning Date
- IMNM 03-19-2025
- WLKP 04-30-2025
- Dividend Yield
- IMNM N/A
- WLKP 8.17%
- EPS Growth
- IMNM N/A
- WLKP 14.91
- EPS
- IMNM N/A
- WLKP 1.77
- Revenue
- IMNM $9,041,000.00
- WLKP $1,135,896,000.00
- Revenue This Year
- IMNM N/A
- WLKP $8.90
- Revenue Next Year
- IMNM $476.80
- WLKP $6.87
- P/E Ratio
- IMNM N/A
- WLKP $13.03
- Revenue Growth
- IMNM N/A
- WLKP N/A
- 52 Week Low
- IMNM $6.41
- WLKP $21.19
- 52 Week High
- IMNM $24.87
- WLKP $25.04
- Technical
- Relative Strength Index (RSI)
- IMNM 29.57
- WLKP 39.24
- Support Level
- IMNM $6.94
- WLKP $23.00
- Resistance Level
- IMNM $7.68
- WLKP $23.45
- Average True Range (ATR)
- IMNM 0.55
- WLKP 0.33
- MACD
- IMNM -0.15
- WLKP -0.03
- Stochastic Oscillator
- IMNM 10.39
- WLKP 11.09
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.